Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,186,600
in 2 filings

Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PERRY MICHAEL S −$1.0M Director sold 9% of stake
  2. OLUKOTUN ADEOYE Y −$174K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-17 GIVEN DOUGLAS B Director Sale −500 $79.59 $40K 15,000
2020-12-10 Waddill William D. Director Sale −1,200 $68.50 $82K 26,800
2020-12-10 Waddill William D. Director Sale −1,800 $73.10 $132K 25,000
2020-12-09 Anzalone Christopher Richard Chief Executive Officer Option exercise +38,676 $2.01 $78K 2,543,913
2020-12-09 Anzalone Christopher Richard Chief Executive Officer Sale −16,726 $67.27 $1.1M 2,527,187
2020-12-09 Anzalone Christopher Richard Chief Executive Officer Sale −12,067 $69.80 $842K 2,515,120
2020-12-09 Anzalone Christopher Richard Chief Executive Officer Sale −5,880 $70.87 $417K 2,509,240
2020-12-09 Anzalone Christopher Richard Chief Executive Officer Sale −4,003 $71.61 $287K 2,505,237
2020-12-09 Anzalone Christopher Richard Chief Executive Officer Option exercise · Stock Option (right to buy) −38,676 840,543
2020-12-08 Anzalone Christopher Richard Chief Executive Officer Option exercise +16,324 $2.01 $33K 2,521,561
2020-12-08 Anzalone Christopher Richard Chief Executive Officer Sale −16,324 $67.97 $1.1M 2,505,237
2020-12-08 Anzalone Christopher Richard Chief Executive Officer Option exercise · Stock Option (right to buy) −16,324 879,219
2020-12-07 GIVEN DOUGLAS B Director Gift −31,000 123,813
2020-12-07 GIVEN DOUGLAS B Director Gift +15,500 15,500
2020-12-07 GIVEN DOUGLAS B Director Gift +15,500 15,500
2020-12-04 O'Brien Patrick General Counsel Gift −800 348,075
2020-11-20 Bradshaw Curt Chief Scientific Officer Sale −15,625 $68.73 $1.1M 0
2020-11-19 Bradshaw Curt Chief Scientific Officer Sale −15,625 $69.39 $1.1M 15,625
2020-11-19 San Martin Javier Chief Medical Officer Sale −19,500 $69.39 $1.4M 130,500
2020-11-09 Myszkowski Kenneth Allen Chief Financial Officer Option exercise +43,505 $14.54 $633K 471,173

Page 21 of 38 · 752 trades